What is AIXC's earnings growth forecast for 2025-2025?
(NASDAQ: AIXC) Aixcrypto Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Aixcrypto Holdings's earnings in 2025 is -$8,963,995.
In 2025, AIXC is forecast to generate -$3,737,149 in earnings, with the lowest earnings forecast at -$3,590,594 and the highest earnings forecast at -$3,847,066.
What is AIXC's revenue growth forecast for 2025-2025?
(NASDAQ: AIXC) Aixcrypto Holdings's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Aixcrypto Holdings's revenue in 2025 is $0.
In 2025, AIXC is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.
What is AIXC's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: AIXC) forecast ROA is -8.6%, which is lower than the forecast US Biotechnology industry average of 7.26%.
What is AIXC's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: AIXC) Aixcrypto Holdings's current Earnings Per Share (EPS) is -$0.12. In 2025, AIXC's EPS is forecast to hit -$0.72 (min: -$0.70, max: -$0.75).
What is AIXC's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: AIXC) forecast ROE is -9.7%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.